Aitia is the leader in leveraging the convergence of patient multiomic and outcome data, high-performance computing, and causal learning and AI to reveal the deeply complex circuitry of human biology to identify novel targets driving disease and focused patient recruitment for clinical development. With this new knowledge, which we capture in our Gemini Digital Twins (computational representatives) of human disease, we work with pharmaceutical partners to apply our discoveries to the next generation of breakthrough therapies.
Company Details
- Employees
- 85
- Founded
- -
- Address
- 561 Windsor St, Somerville,massachusetts 02143,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Data Analytics, Bioinformatics, Genomics Data, Big Data, Causal AI, Drug Discovery, Virtual Patient, In silico trials, Clinical Trial, Virtual Patient, Drug Discovery, Target Discovery, multi-omic patient data, oncology, neurodegenerative disorders, Gemini Digital Twins, Digital Twins, Gemini, Generative AI.
- HQ
- Somerville, Massachusetts
Aitia Questions
Aitia's LinkedIn profile is https://www.linkedin.com/company/aitiabio
Aitia has
85 employees.
View email and phone details for 85
employees at Aitia.
Aitia's industry is
Biotechnology Research
Aitia's top competitors are
Tempus Ai,
Empress Therapeutics,
Aitia Biotech,
Servier,
Generate:biomedicines,
Getfocus,
Immunai,
Orion Pharma,
Pangaea Data,
Concertai.
Aitia's categories are Biotechnology Research
Aitia's founding year is 2000
